PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales and Scotland, PrEP is available through NHS sexual health clinics.It is also...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • British Columbia government drags feet on HIV-prevention drug coverage

    In a statement to Xtra, the BC Ministry of Health says it will not be rolling out coverage of the HIV-prevention drugs anytime soon, despite a May 2017 interview in which now-premier John Horgan said it was a “mystery” why PrEP wasn’t already covered.

    19 hours ago | Xtra
  • PrEP-ing for HIV prevention in Ireland

    Lack of access to HIV pre-exposure prophylaxis (PrEP) is presenting dilemmas for the HSE, clinicians, the medicines regulator and those seeking the medication in Ireland. A recent memo to healthcare professionals sent on behalf of the HSE’s Working Group on HIV pre-exposure prophylaxis (PrEP), discouraging them from directing patients to the activist-led website www.iwantPrEPnow.co.uk for information on sourcing pre-emptive antiretroviral therapy online, is a talking point among campaigners advocating for access.

    18 September 2017 | The Medical Independent
  • Save Microbicide Research and Development

    Ongoing funding and support for vaginal and rectal microbicide research and development is in serious danger! Let NIAID know you want the research to continue.

    18 September 2017 | IRMA
  • How you can help to prevent HIV

    Whether through testing regularly, using condoms, taking preventative drugs or becoming 'undetectable', a new campaign is encouraging Londoners to 'do it your way'.

    18 September 2017 | Evening Standard
  • Kenya Embraces New Prevention Efforts to Reduce HIV Infection

    Kenya’s health authorities launched a new way to reduce the spread of HIV among its people. It is the second African country after South Africa to have pre-exposure prophylaxis guidelines .

    13 September 2017 | The Conversation
  • A Virtual HIV Clinic Could Be the Precursor to Anonymous Online STD Testing

    A new program being run in partnership with the University of Iowa Health Care is offering people at risk of HIV infection the option to seek PrEP online, via video conferencing. The program creates what is basically a virtual HIV clinic, an innovative way to get around the social stigmas associated with HIV.

    12 September 2017 | Video Conferencing Daily
  • Generic PrEP in France and Scotland challenges access across the UK

    The issue of drug procurement and pricing is complex but it is difficult to see how different patents should apply within Europe, and especially not within the UK.

    08 September 2017 | HIV i-Base
  • 5 things you need to know to join the IMPACT trial

    The PrEP IMPACT trial is a clinical trial in England and will operate differently to the ways you usually get sexual health services. You'll need to meet eligibility criteria to go on the trial, and you'll need to read and sign paperwork before you start. You'll also be asked to visit your trial clinic every 3 months for HIV and STI tests. The PrEP IMPACT trial starts in September 2017 – and there are 5 important sets of things you need to know if you’re thinking about joining the trial.

    07 September 2017 | PrEPster
  • Anti-HIV pill safe among gay, bisexual adolescent boys

    A pill that protects against the human immunodeficiency virus (HIV) can be safely used by young men who have sex with men, according to a new study. “I do hope clinicians increase their comfort with being able to provide PrEP to adolescents,” said lead author Sybil Hosek.

    06 September 2017 | Reuters
  • Did HIV Pharma “Pay to Delay” Generic Truvada?

    AIDS activists urge the N.Y. attorney general to investigate possible antitrust violations regarding the HIV med used as PrEP.

    04 September 2017 | Poz
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.